ISSN (Print):
1871-5303
ISSN (Online):
2212-3873
Download PDF Flyer

Endocrine, Metabolic & Immune Disorders - Drug Targets

(Formerly as Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Impact Factor: 2

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed... View all

Volume 24 , Issues 15, 2024

Back Journal Home

Institutional Members
Impact Factor
Web of Science Impact Factor

Current: 2
5 - Year: 2.2

Ranking & Category

  • 110th of 143 in Endocrinology & Metabolism
  • 126th of 155 in Immunology
  • 172nd of 261 in Pharmacology & Pharmacy

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

This journal is devoted to full-length/ mini-reviews and original articles based on experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbiome composition are welcome. The journal’s scope also covers neuroendocrinology, reproductive endocrinology, hormone secretion, and their effects on different organs.

Society Accreditation

The Official Journal of Associazione Medici Endocrinologi
COPE Compliant
Archived in
Special Offers
Endorsement(s)

"EMID-DT is a prestigious journal with a multidisciplinary coverage. Its aim is to provide cutting- edge information to readers working in different field of research ranging from immune endocrine to metabolic disorders."

Chris Galanos
Max Planck Institude, Germany

© 2024 Bentham Science Publishers | Privacy Policy